EVALUATE CDK4/6 INHIBITOR PD0332991 ALONE/WITH RADIATION IN DIPG MOUSE MODEL

在 DIPG 小鼠模型中单独/使用辐射评估 CDK4/6 抑制剂 PD0332991

基本信息

  • 批准号:
    8363197
  • 负责人:
  • 金额:
    $ 0.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Aim 1. To evaluate whether treatment with PD0332991 will prolong the survival of mice harboring DIPG driven by PDGF signaling and loss of Ink4a-ARF Aim 2. To investigate whether in vivo synchronization of DIPG tumors cells with PD0332991 can increase the efficacy of radiation therapy When working with this model in a previous institution, I have only used T2 weighted imaging to image the tumor-bearing mice prior to treatment. However, it would be useful to carry out T1+contrast studies as we are also interested in studying the blood-brain-barrier (BBB) and in the future will be generating tumor-bearing mice with impaired BBB. I would suggest that we do T1+contrast studies on a couple of select mice with a nice size tumor on T2. Ultimately, data from this project will be used for an R01 submission at the end of this year.
这个子项目是利用这些资源的众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oren Josh Becher其他文献

Oren Josh Becher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oren Josh Becher', 18)}}的其他基金

The role of Myeloid cells in pediatric-high grade gliomas
骨髓细胞在儿童高级别胶质瘤中的作用
  • 批准号:
    10391024
  • 财政年份:
    2022
  • 资助金额:
    $ 0.31万
  • 项目类别:
The role of Myeloid cells in pediatric-high grade gliomas
骨髓细胞在儿童高级别胶质瘤中的作用
  • 批准号:
    10626717
  • 财政年份:
    2022
  • 资助金额:
    $ 0.31万
  • 项目类别:
Functional Dissection of the K27M Histone Mutation In Gliomagenesis
胶质瘤发生中 K27M 组蛋白突变的功能剖析
  • 批准号:
    10581204
  • 财政年份:
    2022
  • 资助金额:
    $ 0.31万
  • 项目类别:
Role of the K27M histone mutation in midline gliomas initiated in oligodendrocyte progenitors
K27M 组蛋白突变在少突胶质细胞祖细胞中引发的中线神经胶质瘤中的作用
  • 批准号:
    10058297
  • 财政年份:
    2019
  • 资助金额:
    $ 0.31万
  • 项目类别:
Functional Dissection of the K27M Histone Mutation in Vivo
体内 K27M 组蛋白突变的功能解析
  • 批准号:
    9337512
  • 财政年份:
    2017
  • 资助金额:
    $ 0.31万
  • 项目类别:
FUNCTIONAL DISSECTION OF THE K27M HISTONE MUTATION IN GLIOMAGENESIS
胶质瘤发生中 K27M 组蛋白突变的功能解剖
  • 批准号:
    10117195
  • 财政年份:
    2016
  • 资助金额:
    $ 0.31万
  • 项目类别:
Functional Dissection of the K27M Histone Mutation in Vivo
体内 K27M 组蛋白突变的功能解析
  • 批准号:
    8677666
  • 财政年份:
    2014
  • 资助金额:
    $ 0.31万
  • 项目类别:
Functional Dissection of the K27M Histone Mutation in Vivo
体内 K27M 组蛋白突变的功能解析
  • 批准号:
    9134879
  • 财政年份:
    2014
  • 资助金额:
    $ 0.31万
  • 项目类别:
Functional Dissection of the K27M Histone Mutation in Vivo
体内 K27M 组蛋白突变的功能解析
  • 批准号:
    8826199
  • 财政年份:
    2014
  • 资助金额:
    $ 0.31万
  • 项目类别:

相似海外基金

SCREENING FOR ABNORMALITIES IN CDK4 GENE IN PATIENTS W/ TYPE 1 & TYPE
筛查 1 型患者的 CDK4 基因异常
  • 批准号:
    6264831
  • 财政年份:
    1998
  • 资助金额:
    $ 0.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了